| Application no. and date | 99927894.8 (espacenet) (Federated) (European Patent Register), 19990607 | | Patent/reg. no. and date | DK/EP 1087980, 20030129 | | Publication date | 20010404 | | Priority no. and date | EP 98110888, 19980615, EP 98117099, 19980910 | | EP pub. no. and date |
EP 1087980 20010404 | | Effective date | | | Applicant/owner | Basilea Pharmaceutica AG, c/o Rudolf Maag,
Neuhofweg 11
4102 Binningen, CH,
Basilea Pharmaceutica AG, Neuhofweg 11
4102 Binningen, CH | | Applicant ref. no. | 34348 DK 01 | | Inventor | HUBSCHWERLEN, Christian, Rue de la Gendarmerie
F-68200 Durmenach, FR,
SPECKLIN, Jean-Luc, 2, rue des Faisans
F-68680 Kembs-Schaferhof, FR,
HEBEISEN, Paul, St. Alban-Ring 184
CH-4052 Basle, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/545 (2006.01) , C07D 501/56 (2006.01) | | Title | 3-[2-oxo-(1,3')bipyrrolidinyl-3-yliden-methyl]-cephemderivater | | Int. application no. | EP1999003907 | | Int. publication no. | WO1999065920 | | Related patent (certificate) | CA 2013 00067 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
